These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16754543)

  • 1. Attention-deficit/hyperactivity disorder: a plausible mouse model?
    Granon S; Changeux JP
    Acta Paediatr; 2006 Jun; 95(6):645-9. PubMed ID: 16754543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurobiology of attention deficit/hyperactivity disorder].
    Purper-Ouakil D; Lepagnol-Bestel AM; Grosbellet E; Gorwood P; Simonneau M
    Med Sci (Paris); 2010 May; 26(5):487-96. PubMed ID: 20510147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiology of animal models of attention-deficit hyperactivity disorder.
    Russell VA
    J Neurosci Methods; 2007 Apr; 161(2):185-98. PubMed ID: 17275916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?
    Potter AS; Newhouse PA; Bucci DJ
    Behav Brain Res; 2006 Dec; 175(2):201-11. PubMed ID: 17081628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex.
    D'Agati E; Moavero R; Cerminara C; Curatolo P
    J Child Neurol; 2009 Oct; 24(10):1282-7. PubMed ID: 19805824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.
    Genro JP; Kieling C; Rohde LA; Hutz MH
    Expert Rev Neurother; 2010 Apr; 10(4):587-601. PubMed ID: 20367210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rodent models: utility for candidate gene studies in human attention-deficit hyperactivity disorder (ADHD).
    Mill J
    J Neurosci Methods; 2007 Nov; 166(2):294-305. PubMed ID: 17234273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review.
    Sontag TA; Tucha O; Walitza S; Lange KW
    Atten Defic Hyperact Disord; 2010 Mar; 2(1):1-20. PubMed ID: 21432586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ADHD and attachment processes: are they related?].
    Franc N; Maury M; Purper-Ouakil D
    Encephale; 2009 Jun; 35(3):256-61. PubMed ID: 19540412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder.
    van der Kooij MA; Glennon JC
    Neurosci Biobehav Rev; 2007; 31(4):597-618. PubMed ID: 17316796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pozanicline for the treatment of attention-deficit/hyperactivity disorder.
    Childress A; Sallee FR
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1585-93. PubMed ID: 25196198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental risk factors for attention-deficit hyperactivity disorder.
    Banerjee TD; Middleton F; Faraone SV
    Acta Paediatr; 2007 Sep; 96(9):1269-74. PubMed ID: 17718779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program.
    Lerman C; Audrain J; Tercyak K; Hawk LW; Bush A; Crystal-Mansour S; Rose C; Niaura R; Epstein LH
    Nicotine Tob Res; 2001 Nov; 3(4):353-9. PubMed ID: 11694203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How does maternal alcohol consumption during pregnancy affect the development of attention deficit/hyperactivity syndrome in the child].
    Burger PH; Goecke TW; Fasching PA; Moll G; Heinrich H; Beckmann MW; Kornhuber J
    Fortschr Neurol Psychiatr; 2011 Sep; 79(9):500-6. PubMed ID: 21739408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to date.
    Potter AS; Schaubhut G; Shipman M
    CNS Drugs; 2014 Dec; 28(12):1103-13. PubMed ID: 25349138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of attention in children with attention deficit hyperactivity disorder (an analytical review)].
    Krupskaia EV; Machinskaia RI
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2006; 56(6):731-41. PubMed ID: 17285768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
    Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
    Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rodent models of attention-deficit/hyperactivity disorder.
    Sagvolden T; Russell VA; Aase H; Johansen EB; Farshbaf M
    Biol Psychiatry; 2005 Jun; 57(11):1239-47. PubMed ID: 15949994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic haplotype as a predictor of spatial inattention in children with attention-deficit/hyperactivity disorder.
    Bellgrove MA; Johnson KA; Barry E; Mulligan A; Hawi Z; Gill M; Robertson I; Chambers CD
    Arch Gen Psychiatry; 2009 Oct; 66(10):1135-42. PubMed ID: 19805704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interference of local over global information processing in children with attention deficit hyperactivity disorder of the inattentive type.
    Song Y; Hakoda Y
    Brain Dev; 2012 Apr; 34(4):308-17. PubMed ID: 21862271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.